- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Baricitinib is suitable for patients with specific rheumatic and immune diseases, but its safety needs to be evaluated based on age, liver and ...
Baricitinib, as a JAK inhibitor, should be used with a focus on infection risk, thrombotic events, and medication safety in special populations...
Seladelar is a selective peroxisome proliferator activated receptor delta (PPAR delta) agonist primarily used for the treatment of cholestatic ...
The side effects of Seladelpar mainly include abnormal liver function, gastrointestinal reactions, and neurological symptoms. Specific relief m...
The side effects of Voranigo mainly include skin reactions, eye toxicity, and venous thromboembolism, most of which can be alleviated through p...
Voranigo is an oral targeted drug mainly used to treat cancer patients with specific gene mutations. Its usage and dosage need to be adjusted a...
Voranigo is suitable for patients with specific gene mutations, but there are strict restrictions such as pregnancy ban and dosage adjustment f...
When using Voranigo, special attention should be paid to drug interactions, liver function monitoring, and medication risks for special populat...
Dalafenib mesylate capsules are a kinase inhibitor targeting BRAF V600 gene mutations, mainly used to treat various malignant tumors carrying t...
The side effects of dalafenib mesylate capsules mainly include skin reactions, fever, joint pain, etc. Most of them can be relieved through p...
